Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OZAWADE 4,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/OZAWADE 4,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

OZAWADE 4,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Bioprojet Pharma🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 11, 2021
Approval ID: 76df3b926c4b3adf
Company: Bioprojet Pharma
Type: Standard

Approval Details

Approval Id: 76df3b926c4b3adf
Drug Cima Aemps Name: OZAWADE 4,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1211546001
Holder Company Name: Bioprojet Pharma
Marketing Company Name: Bioprojet Pharma
Holder Company Detail Path: /organization/bioprojet-pharma
Marketing Company Detail Path: /organization/bioprojet-pharma
Authorization Date: 2021-11-11
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 4,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Bioprojet Pharma
Company Detail Path: /organization/bioprojet-pharma

Company Information

Pharmaceutical Company Name: Bioprojet Pharma
Country Name: Belgium
City Name: unknown,unknown,country_be
Address: Unknown Belgian address

Active Ingredients

PITOLISANT HIDROCLORURO

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 11, 2021

Approval ID

76df3b926c4b3adf

Type

Standard

Back to CIMA-AEMPS Approvals